Pharma deal potentially great news, but there are worries over funding
1 December 2025
Daniel Elkeles responds to the UK-US pharmaceuticals deal.
Finance
Prevention
Responding to the announcement of the UK-US pharmaceuticals deal, the chief executive of NHS Providers, Daniel Elkeles, said:
"This deal is potentially very good news for patients, for the NHS and for UK life sciences.
"It is great that NHS patients will have increased access to groundbreaking new treatments.
"The announcement also builds on the longstanding close partnership between the NHS and the pharmaceutical industry, making this the best place in the world to carry out clinical trials.
"However it is not yet clear how it will be paid for.
"There is absolutely no slack in current published NHS spending plans for this major commitment and that is a real worry for trust leaders."
Related articles
- Insights
Forging strategic partnerships: considerations for delivering the 10 Year Health Plan
16 Mar 2026Insights around key areas including shared infrastructure, creating one workforce, contracting and financial flows, and getting governance right.
Integration
Finance
- News
Underfunding mental health is not just bad for patients but for wider communities and economy, health leaders say
12 Mar 2026Rebecca Gray, mental health director speaking on behalf of the NHS Confederation and NHS Providers responded to the government’s announcement on mental health spending.
Mental health
Finance
Delivery and performance
Health inequalities
InsightsTransforming ambulance services in the south east
4 Mar 2026After leading transformation at South East Coast Ambulance Trust, Simon Weldon believes transforming the ambulance sector is essential for the NHS.
Regulation
Finance